Tuesday, January 29, 2013

Researchers call for more stringent FDA oversight of medtech

Researchers call for more stringent FDA oversight of medtech-massdevice: MASSDEVICE ON CALL — A commentary co-authored by the California and Australian researchers called for the FDA to close the 510(k) "loophole" that allows medical devices considered a potentially "high risk" to patients to enter the U.S. market without undergoing clinical trials.